Skip to content
healthcare.dev

MiraLAX

NDC 55154-5035, Polyethylene Glycol 3350, powder, for solution, from Cardinal Health 107, LLC.

Product NDC
55154-5035
Status
Listed
Labeler
Cardinal Health 107, LLC
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA022015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55154-5035 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
55154-5035-6551545035066 PACKET in 1 BAG (55154-5035-6) / 17 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55154-5035 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55154-5035 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55154-5035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.